Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.18% | $3.76B | €458.38B | 86.92% | 76 Outperform | |
| AstraZeneca | 1.24% | $2.13B | $305.49B | 27.65% | 80 Outperform | |
| Roche Holding AG | 1.23% | $2.11B | CHF268.16B | 29.32% | 73 Outperform | |
| Novartis AG | 1.21% | $2.08B | CHF232.19B | 30.93% | 80 Outperform | |
| HSBC Holdings | 1.19% | $2.06B | £219.84B | 52.09% | 80 Outperform | |
| Nestlé SA | 1.07% | $1.84B | CHF201.30B | 0.07% | 71 Outperform | |
| Shell (UK) | 0.98% | $1.70B | £179.19B | 24.58% | 73 Outperform | |
| Toyota Motor | 0.85% | $1.47B | ¥45.26T | 26.08% | 80 Outperform | |
| Commonwealth Bank of Australia | 0.83% | $1.44B | AU$287.21B | 16.93% | 64 Neutral | |
| SAP SE | 0.83% | $1.43B | €193.11B | -29.30% | 66 Neutral |